These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2157062)

  • 21. Identification of an enhancer-type sequence that is responsive to Z and R trans-activators of Epstein-Barr virus.
    Shimizu N; Sakuma S; Ono Y; Takada K
    Virology; 1989 Oct; 172(2):655-8. PubMed ID: 2552665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Epstein-Barr virus BZLF1 gene product activates the human immunodeficiency virus type 1 5' long terminal repeat.
    Mallon R; Borkowski J; Albin R; Pepitoni S; Schwartz J; Kieff E
    J Virol; 1990 Dec; 64(12):6282-5. PubMed ID: 2173793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
    Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
    J Virol; 2017 May; 91(9):. PubMed ID: 28228591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.
    Graham GJ; Maio JJ
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5817-21. PubMed ID: 1696012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional activation of Epstein-Barr virus BRLF1 by USF1 and Rta.
    Hung CC; Kuo CW; Wang WH; Chang TH; Chang PJ; Chang LK; Liu ST
    J Gen Virol; 2015 Sep; 96(9):2855-2866. PubMed ID: 26297580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism.
    Furnari FB; Zacny V; Quinlivan EB; Kenney S; Pagano JS
    J Virol; 1994 Mar; 68(3):1827-36. PubMed ID: 8107245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
    Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
    J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.
    Cox MA; Leahy J; Hardwick JM
    J Virol; 1990 Jan; 64(1):313-21. PubMed ID: 2152819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis.
    Feng P; Ren EC; Liu D; Chan SH; Hu H
    J Gen Virol; 2000 Oct; 81(Pt 10):2417-2423. PubMed ID: 10993929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
    Le Roux A; Kerdiles B; Walls D; Dedieu JF; Perricaudet M
    Virology; 1994 Dec; 205(2):596-602. PubMed ID: 7975264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation.
    Darr CD; Mauser A; Kenney S
    J Virol; 2001 Jul; 75(13):6135-42. PubMed ID: 11390615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the Epstein-Barr viral immediate early BRLF1 promoter through a distal NF1 site.
    Glaser G; Vogel M; Wolf H; Niller HH
    Arch Virol; 1998; 143(10):1967-83. PubMed ID: 9856084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2.
    Levrero M; Balsano C; Natoli G; Avantaggiati ML; Elfassi E
    J Virol; 1990 Jun; 64(6):3082-6. PubMed ID: 2335828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis.
    Flemington EK; Goldfeld AE; Speck SH
    J Virol; 1991 Dec; 65(12):7073-7. PubMed ID: 1658397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.
    Lieberman PM; Hardwick JM; Sample J; Hayward GS; Hayward SD
    J Virol; 1990 Mar; 64(3):1143-55. PubMed ID: 2154599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
    J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
    Laux G; Dugrillon F; Eckert C; Adam B; Zimber-Strobl U; Bornkamm GW
    J Virol; 1994 Nov; 68(11):6947-58. PubMed ID: 7933076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans-activators.
    Manet E; Gruffat H; Trescol-Biemont MC; Moreno N; Chambard P; Giot JF; Sergeant A
    EMBO J; 1989 Jun; 8(6):1819-26. PubMed ID: 2548857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.